Cv. Fernandez et al., ALTERNATIVE AND COMPLEMENTARY THERAPY USE IN PEDIATRIC ONCOLOGY PATIENTS IN BRITISH-COLUMBIA - PREVALENCE AND REASONS FOR USE AND NONUSE, Journal of clinical oncology, 16(4), 1998, pp. 1279-1286
Purpose: Alternative and complementary therapies are infrequently stud
ied in pediatric populations. We performed a population-based survey t
o aid health care workers in identifying and counseling parents who ma
y use these remedies. Patients and Methods: We retrospectively surveye
d the parents of 583 pediatric patients diagnosed with cancer in Briti
sh Columbia between 1989 and 1995. Prevalence and factors that influen
ce che use and non-use of alternative and complementary therapies were
estimated, Results: Alternative and complementary therapies were used
by 42% of 366 respondents, Herbal teas, plant extracts, and therapeut
ic vitamins were the most commonly used alternative therapies. Relaxat
ion/imagery strategies, massage, and therapeutic couch were the most c
ommonly used complementary techniques. Factors that influenced the use
of alternative/complementary therapies were prior use (chi(2) = 60.0,
P < .0001), prior positive attitude cowards these remedies (chi(2) =
41.6, P < .0001), soliciting information from family and friends (chi(
2) = 70.5, P < .0001) or from alternative care givers (chi(2) = 58.7,
P < .0001), high risk of death at diagnosis (chi(2) = 9.6, P < .002),
and advanced education of the father (chi(2) = 7.4, P < .006) or mothe
r (chi(2) = 8.6, P < .003). Parents who used alternative/complementary
therapies did so in conjunction with conventional medicine (98%). Lac
k of knowledge and fear of interference with conventional therapies we
re che most common reasons cited for nonuse. Ho parent believed that t
he quality of life of their child deteriorated due to the use of alter
native/complementary therapies. Conclusion: Alternative and complement
ary therapy use in pediatric oncology patients is common, Factors have
been identified that may be associated with undertaking their use, (C
) 1998 by American Society of Clinical Oncology.